With offices in over 50 countries, we’re in the best position for clinical monitoring – literally. Our teams all have local knowledge so they understand the nuances involved in each market; from regulatory differences to cultural sensitivities. We initiate projects quickly, with teams primed and ready to push the process through.
Flexible Monitoring Model
We’re constantly adapting and finding new, innovative ways to deliver. Always one step ahead, we’re all set for the ICH-GCP E6 amendment and fully prepared for the wider guideline changes anticipated in 2018.
Our flexible monitoring platform handles risk-based monitoring, targeted monitoring and centralized monitoring support, as well as more traditional monitoring models.
We have a wealth of experience across all therapeutic areas, including specialist disciplines such as oncology phase II-III studies and rare disease projects. Here, our global connections and all-round expertise have proved critical in gaining access to the right patients.
The right team
Monitoring is the backbone of any study. For us, it’s as much about people as it is data. We’ll connect you with Clinical Research Associates who’ll work with you on-site, as part of your team. They know your territory and all of its laws, regulations and guidelines – and they bring the motivation, passion and commitment to maximize the potential of everyone involved.
Our ongoing qualitative training and mentorship program ensures our team stays motivated, engaged, informed, and always able to provide a service of the very highest quality.
Our people are our greatest asset. Clinical business performance (CBP) metrics gauge our performance and we use that data to ensure excellence in our clinical monitoring teams.
We also offer a unique Site Quality Control service – to ensure you are audit ready.